Carbohydrate Loading and Diabetes in Colorectal Surgery
In Individuals With Diabetes Undergoing Elective Colorectal Surgery, Is Carbohydrate Loading Preoperatively Safe? A Pilot Randomized Controlled Trial
1 other identifier
interventional
71
1 country
1
Brief Summary
The goal of this study is to evaluate the feasibility of conducting a large study that would assess the safety of carbohydrate drinks (i.e. juice) prior to elective colorectal surgery in patients with type 2 diabetes. Traditionally, prior to surgeries involving a general anesthetic, patients have been told not to eat or drink anything after midnight due to the risk of aspiration. More recent research have shown that it is safe to have clear fluids up to 2 hours before an operation and this is reflected in the current anesthesia clinical guidelines. Moreover, it has been shown that subjecting patients to a state of starvation causes stress on the body that may lead to complications such as poor wound healing, infections, and delayed return to bowel function. A sugar drink before surgery has been shown to be beneficial and can lead to decreased complication rates and decreased length of stay after surgery. However, it is currently not known if it is safe for patients with type 2 diabetes to have a sugar drink before their surgery since they have trouble processing sugars and a subset of patients with diabetes are at increased risk of aspiration due to delayed stomach emptying. This feasibility study is designed to answer the question of whether a large scale trial can be conducted examining the benefits of a pre-operative sugar drink in patients with type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Mar 2018
Longer than P75 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 22, 2020
CompletedFirst Posted
Study publicly available on registry
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedAugust 21, 2025
August 1, 2025
6.8 years
May 22, 2020
August 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Mean difference of preoperative glucose between the two groups
Examined in a non-inferiority fashion with NI margin set as 2mmol/L
Pre-operative
Secondary Outcomes (6)
Composite outcome of diabetes-related complications
Within 30 days of surgery or to discharge
length of stay
Within 30 days of surgery or to discharge
Surgical site infection
Within 30 days of surgery or to discharge
Postoperative complications using the Clavien Dindo scale
Within 30 days of surgery or to discharge
Post-operative serum blood glucose concentration
Within 30 days of surgery or to discharge
- +1 more secondary outcomes
Study Arms (2)
Standard Care
NO INTERVENTIONStandard care for patients with diabetes pre-operatively .
Carbohydrate drink
EXPERIMENTALCarbohydrate drink containing 40g of carbohydrate to be consumed three hours prior to surgery
Interventions
Carbohydrate drink containing 40g of carbohydrate to be consumed three hours prior to surgery
Eligibility Criteria
You may qualify if:
- All adult (\>=18 years of age) patients with an established diagnosis of type 2 diabetes mellitus undergoing elective colorectal surgery at the University of Alberta Hospital, the Grey Nuns Hospital, the Royal Alexandra Hospital or the Misericordia Hospital will be eligible. Only patients treated with diet or oral hypoglycemic agents will be included.
You may not qualify if:
- Subjects \<18 years of age, and those on insulin therapy preoperatively will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alberta Hospital
Edmonton, Alberta, T6G 2B7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2020
First Posted
June 1, 2020
Study Start
March 1, 2018
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
August 21, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share